electroCore, Inc. (the “Company”), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce shop for patients residing in the United Kingdom. The site, which can be found at www.gammacore.co.uk, requires patients to complete a healthcare questionnaire in order to purchase a gammaCore Sapphire™, non-invasive vagus nerve stimulator (nVNS) device online.
The first product launched on the platform is designed to treat menstrual migraine, supporting the 60% of women who report migraine symptoms associated with their menstrual cycle. This platform will allow patients to experience a fully virtual experience by completing an online clinical assessment, having product delivered to their door, and being trained via video calls with a member of the UK customer service team.
“We want to make gammaCore more accessible to patients looking to better manage their primary headache conditions. With an estimated 70% of migraineurs being female, the specificity of menstrual migraine is a natural starting point in a new chapter for our business within the online market. We have created a simple assessment process with full clinician oversight offering ongoing customer care as required,” stated Karly Hoggard, Director of Global Commercial Development at electroCore. “Many women suffering from migraine symptoms each month expect to live with such symptoms, impacting daily life, work, family and social commitments. We are excited to offer a clinically proven option women looking for solutions to treat their primary headaches, and through this platform we hope to empower people to take ownership of their conditions and regain control.”
